scispace - formally typeset
C

Claudia Giesecke

Researcher at Charité

Publications -  15
Citations -  1640

Claudia Giesecke is an academic researcher from Charité. The author has contributed to research in topics: Antigen & Antibody. The author has an hindex of 13, co-authored 15 publications receiving 1442 citations. Previous affiliations of Claudia Giesecke include Leibniz Association.

Papers
More filters
Journal ArticleDOI

High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire.

TL;DR: The fidelity of VH:VL pairs identified by this approach were validated and the method was used to sequence the repertoire of three human cell subsets—peripheral blood IgG+ B cells, peripheral plasmablasts isolated after tetanus toxoid immunization and memory B cells isolated after seasonal influenza vaccination.
Journal ArticleDOI

Mechanisms of B cell autoimmunity in SLE

TL;DR: New information has made it possible to distinguish between the contribution played by abnormalities in central checkpoints that could lead to a pre-immune repertoire enriched in autoreactive B cells, and the possibility that autoimmunity arises in the periphery from somatic hypermutation and abnormal selection during T cell-dependent B-cell responses on the other.
Journal ArticleDOI

Identification and characterization of the constituent human serum antibodies elicited by vaccination

TL;DR: The results suggest that only a small fraction of responding peripheral B cells give rise to the bone marrow long-lived plasma cells responsible for the production of biologically relevant amounts of vaccine-specific antibodies in the serological memory response 9 mo postvaccination.
Journal ArticleDOI

Induction of Potent CD8 T Cell Cytotoxicity by Specific Targeting of Antigen to Cross-Presenting Dendritic Cells In Vivo via Murine or Human XCR1

TL;DR: The specificity and efficiency of XCR1-mediated Ag targeting to cross-presenting DC, combined with its lack of adverse effects, make this system a prime candidate for the development of therapeutic cytotoxic vaccines in humans.